MPS Pharmaa Limited has announced that it received one investor complaint during the quarter, which was resolved within the same period.

There were no pending or unresolved complaints at the beginning or end of the quarter.

This reflects the company’s effective handling of investor grievances, supporting shareholder confidence in its investor relations practices.